Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated & Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment With Nuwiq, Octanate or Wilate - Efficacy & Safety Observational Study-Protect-NOW

NCT03695978 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT03695978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03695978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated & Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment With Nuwiq, Octanate or Wilate - Efficacy & Safety Observational Study-Protect-NOW
Lead sponsor
Octapharma
Phase
Observational
Overall status
Recruiting
Start date
February 13, 2018
Completion date
June 30, 2030
Enrollment
200 (estimated)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a